Literature DB >> 21194672

New insights on therapeutic touch: a discussion of experimental methodology and design that resulted in significant effects on normal human cells and osteosarcoma.

Eloise Monzillo1, Gloria Gronowicz.   

Abstract

Our purpose is to discuss the study design and innovative approaches that led to finding significant effects of one energy medicine therapy, Therapeutic Touch (TT), on cells. In the original published studies, TT was shown to significantly increase human osteoblast DNA synthesis, differentiation, and mineralization; increase in a dose-dependent manner the growth of other human cell types; and decrease the differentiation and mineralization of a human osteosarcoma-derived cell line. A unique feature of the study's methodology and design that contributed to the success of the findings was that a basic level of skill and maturity of the TT practitioner was quantified for producing observable and replicable outcomes in a test administered to all TT practitioners. Only those practitioners that passed the test were selected for the study. (2) The practitioners were required to keep a journal, which appeared to promote their ability to stay centered and replicate their treatments over months of cell experimentation. (3) The origin of the cells that the practitioners were treating was explained to them, although they were blinded to cell type during the experiments. (4) Only early passage cells were used to maintain a stable cell phenotype. (5) Standard protocols for performing TT in the room were followed to ensure reproducible conditions. (6) Placebo controls and untreated controls were used for each experiment. (7) The principal investigator and technicians performing the assays were blinded as to the experimental groups, and all assays and procedures were well established in the laboratory prior to the start of the TT experiments. The absence of studies on the human biofield from mainstream scientific literature is also discussed by describing the difficulties encountered in publishing. These roadblocks contribute to our lack of understanding of the human biofield and energy medicine modalities in science. In conclusion, this report seeks to encourage well-designed, evidence-based studies on the human biofield and the therapeutic potential of the human biofield.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21194672     DOI: 10.1016/j.explore.2010.10.001

Source DB:  PubMed          Journal:  Explore (NY)        ISSN: 1550-8307            Impact factor:   1.775


  6 in total

1.  Evaluation of biofield treatment dose and distance in a model of cancer cell death.

Authors:  Garret Yount; Shrikant Patil; Umang Dave; Leonardo Alves-dos-Santos; Kimberly Gon; Robert Arauz; Kenneth Rachlin
Journal:  J Altern Complement Med       Date:  2012-06-25       Impact factor: 2.579

2.  Therapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size.

Authors:  Gloria Gronowicz; Eric R Secor; John R Flynn; Evan R Jellison; Liisa T Kuhn
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-31       Impact factor: 2.629

Review 3.  Neurophysiology of human touch and eye gaze in therapeutic relationships and healing: a scoping review.

Authors:  Fiona Kerr; Rick Wiechula; Rebecca Feo; Tim Schultz; Alison Kitson
Journal:  JBI Database System Rev Implement Rep       Date:  2019-02

Review 4.  Challenges for Preclinical Investigations of Human Biofield Modalities.

Authors:  Gloria Gronowicz; William Bengston; Garret Yount
Journal:  Glob Adv Health Med       Date:  2015-11-01

Review 5.  Energy therapies in advanced practice oncology: an evidence-informed practice approach.

Authors:  Pamela J Potter
Journal:  J Adv Pract Oncol       Date:  2013-05

Review 6.  Perspectives, Measurability and Effects of Non-Contact Biofield-Based Practices: A Narrative Review of Quantitative Research.

Authors:  Luís Carlos Matos; Jorge Pereira Machado; Fernando Jorge Monteiro; Henry Johannes Greten
Journal:  Int J Environ Res Public Health       Date:  2021-06-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.